Braxton v. Amchem Products

CourtSuperior Court of Delaware
DecidedOctober 8, 2024
DocketN23C-02-129 ASB
StatusPublished

This text of Braxton v. Amchem Products (Braxton v. Amchem Products) is published on Counsel Stack Legal Research, covering Superior Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Braxton v. Amchem Products, (Del. Ct. App. 2024).

Opinion

IN THE SUPERIOR COURT OF THE STATE OF DELAWARE

IN RE: ASBESTOS LITIGATION ) C.A. No.: N23C-02-129 ASB ) LIMITED TO: ) ASBESTOS ) LADONNA SUE BRAXTON, ) JURY TRIAL DEMANDED Individually and as Independent ) Executrix of the Estate of MARVIN ) JERRY BRAXTON, JR., deceased ) )

ORDER

Upon Consideration of Plaintiff’s Opposition to Defendant J-M Manufacturing Company, Inc.’s Motion for Summary Judgment on the Insufficiency of Plaintiff’s Expert Reports DENIED.

Submitted: September 12, 2024 Decided: October 8, 2024

This 8th day of October 2024, upon consideration of J-M Manufacturing

Company, Inc.’s (“J-M”) Motion for Reargument and Plaintiff’s Response, it appears

to the Court that:

1. On August 28, 2024, this Court issued a decision in this asbestos case denying

Summary Judgment to J-M. J-M moved for summary judgment arguing that

Plaintiff’s expert reports were insufficient to meet the stringent causation

standard under Texas law. This Court found that Plaintiff’s expert, Kenneth

Garza’s report, was sufficient to meet the Texas standard. Specifically, this

1 Court found that under the unique circumstances of this case that Plaintiff did

not have to calculate the aggregate dose of asbestos from all products and that

the epidemiological studies in Garza’s reports were sufficiently similar to

form a reliable basis for Garza’s opinion.

2. In this Court’s August 28 ruling, the Court found that Texas law does not

require an aggregate or cumulative exposure calculation in all cases, even

where there is exposure from multiple sources. J-M takes issue with this

ruling maintaining that the Court has overlooked Texas law on this point and

that Texas law requires an aggregate dose calculation in every case where

there are multiple exposures.

3. The purpose of moving for reargument to seek reconsideration of findings of

fact, conclusions of law, or judgment of law.1 Reargument usually will be

denied unless the moving party demonstrates that the Court over looks a

precedent or legal principle that would have a controlling effect, or that it has

misapprehended the law or the facts in a manner affecting the outcome of the

decision.2 “A motion for reargument should not be used merely to rehash the

arguments already decided by the court.” 3 To the extent the parties asserted

issues that were not raised in the submissions in support of summary judgment

1 Hessler, Inc. v. Farrell, 260 A.2d 701, 702 (Del. 1969). 2 Ferguson v. Vakili, 2005 WL 628026, at *1 (Del. Super.). 3 Wilmington Trust Co. v. Nix, 2002 WL 356371, at *1 (Del. Super.).

2 motions, new arguments may not be presented for the first time in a motion

for reargument. 4

4. The Court has reviewed and considered the parties’ written submissions and

arguments. The Court did not overlook a controlling precedent or legal

principle, or misapprehend the law or the facts in a manner affecting the

outcome of the decision.

THEREFORE, Defendant’s Motion for Reargument is DENIED.

IT IS ORDERED.

/s/ Francis J. Jones, Jr. Francis J. Jones Jr., Judge

cc: Original to the Prothonotary Adam Balick, Esquire Bartholomew J. Dalton, Esquire

4 Oliver v. Boston University, 2006 WL 4782232, at *1 (Del. Ch.).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hessler, Inc. v. Farrell
260 A.2d 701 (Supreme Court of Delaware, 1969)

Cite This Page — Counsel Stack

Bluebook (online)
Braxton v. Amchem Products, Counsel Stack Legal Research, https://law.counselstack.com/opinion/braxton-v-amchem-products-delsuperct-2024.